Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy

Cancer and Metastasis Reviews

Volumn 17, Issue 1, 1998, Pages 1-6

  Lala, P K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cancer therapy; Carcinogenesis; Metastasis; Nitric oxide; Nitric oxide synthase; Tumor progression

Indexed keywords

AMINOGUANIDINE; INTERLEUKIN 2; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CAPILLARY PERMEABILITY; CARCINOGENESIS; DOSE RESPONSE; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INDUCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; METASTASIS; MUTAGENESIS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; TUMOR VASCULARIZATION;

ANIMALS; DISEASE PROGRESSION; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS; NITRIC OXIDE;

EID: 0031947858     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005963400984     Document Type: Review

References (26)

1. Furchgott and Zawadeski: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylchone. Nature 288: 377-386, 1980
2. Palmer RMJ, Ferrige AS, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987
3. Culotta E, Koshland DE Jr: NO news is good news. Science 258: 1862-1863, 1993
4. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994
5. Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266: E829-E839, 1994
6. Michel T, Xie QW, Nathan C: Molecular biological analysis of nitric oxide synthases. In: Feelisch M, Stamler J (eds) Methods in Nitric Oxide Research. John Wiley and Sons, NY, 161-175, 1996
7. Gnanapandithen K, Chen Z, Kau CL, Gorenzynski RM, Marsden PA: Cloning and characterization of murine endothelial constitutive nitric oxide synthase. Biochimica et Biophysica Acta 1308: 103-106, 1996
8. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995
9. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995
10. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 175: 1273-1286, 1993
11. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH: Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378; 383-386, 1995
12. Moncada S, Palmer RMJ, Higgs EA: Nitric Oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-112, 1991
13. Bredt DS, Snyder SH: Nitric oxide mediates glulamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033, 1989
14. Stuehr DJ, Nathan CF: Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555, 1989
15. Soo Kwon N, Stuehr DJ, Nathan CF: Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 174: 761-767, 1991
16. Wink D, Kasprazak K, Maragos C, Elespuru R, Misra M, Dumus T, Cebula T, Koch W, Andrews A, Allan J, Keefer L: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001-1003, 1991
17. Beckman JS, Koppenol WH: Nitric Oxide, superoxide and peroxynitrite: The good, the bad and the ugly. Am J Physiol 271: C1424-C1437, 1996
18. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C, Fidler IJ: Transfection with inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995
19. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994
20. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995
21. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995
22. Edwards P, Cendan JC, Topping DB, Moldawer LL, Mackay S, Copeland EM, Lind DS: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 63: 49-52, 1996
23. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 82: 4392-1396, 1995
24. Kennovin GD, Hirst DG, Stratford MRL, Flitney FW: Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumor growth in vivo. In: Moncada S, Feelisch M, Busse R, Higgs EA (eds) Biology of Nitric Oxide, Part 4: Enzymology, Biochemistry and Immunology. Portland Press, London, 1994, pp 473-479
25. Ambs S, Hussain SP, Harris CC: Interactive effects of nitrix oxide and the p53 tumor suppressor gene in earcinogenesis and tumor progression. FASEB J, In press, 1997
26. Kotasek D, Vercellolti GM, Ochoa AC, Bach AC, Bach FH, White JG, Jacobs HS: Mechanisms of cultured endothelial injury induced by lymphokine-activated killer cells. Cancer Res 48: 5528-5532, 1988